Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclophosphamide Plus Cyclosporine in Treatment-Naive Severe Aplastic Anemia
NCT01193283Phase 2Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Aug 2010
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide in aplastic anemia, sponsored by National Heart, Lung, and Blood Institute. Started Aug 2010; status: completed.
02
Drugs
cyclophosphamide
03
Conditions
aplastic anemia
Beyond the preview
Go deeper on NCT01193283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01193283.